Structural imaging is insensitive for detecting the disease process in its early stages
and assessing its response after various therapeutic interventions.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in Clinical RadiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Scintillation camera.Rev Sci Instrum. 1958; 29: 27-33
- Computerized transverse axial scanning (tomography). 1. Description of system.Br J Radiol. 1973; 46: 1016-1022
- Studies of central nervous system disorders with single photon emission computed tomography and positron emission tomography: evolution over the past 2 decades.Semin Nucl Med. 1991; 21: 58-81
- Guest editorial: the conception of FDG-PET imaging.Semin Nucl Med. 2002; 32: 2-5
- A positron-emission transaxial tomograph for nuclear imaging (PETT).Radiology. 1975; 114: 89-98
- Image formation by induced local interactions: examples employing nuclear magnetic resonance.Nature. 1973; 242: 190-191
- Iron oxide MR contrast agents for molecular and cellular imaging.NMR Biomed. 2004; 17 (John Wiley & Sons, Ltd.): 484-499
- Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION).Nano Rev. 2010; 1 (CoAction Publishing)https://doi.org/10.3402/nano.v1i0.5358
- PET/CT scanner instrumentation, challenges, and solutions.Radiol Clin North Am. 2004; 42 (vii): 1017-1032
- PET/MR imaging: clinical applications.PET Clin. 2016; 11: xi-xii
- The role of PET in evaluating atherosclerosis: a critical review.Semin Nucl Med. 2018; 48: 488-497
Ingvar D, Lassen N. Quantitative determination of regional cerebral blood-flow in man. Lancet 1961;278:806–7. Elsevier.
- Glial biomarkers in human central nervous system disease.Glia. 2016; 64: 1755-1771
- Computed tomography use for adults with head injury: describing likely avoidable emergency department imaging based on the Canadian CT Head Rule.Acad Emerg Med. 2017; 24: 22-30
- Potential of PET/CT in assessing dementias with emphasis on cerebrovascular disorders.Eur J Nucl Med Mol Imaging. 2020; https://doi.org/10.1007/s00259-020-04697-y
- PET imaging in the differential diagnosis of vascular dementia.J Neurol Sci. 2012; 322: 268-273
- Novel assessment of global metabolism by 18F-FDG-PET for localizing affected lobe in temporal lobe epilepsy.Nucl Med Commun. 2016; 37: 882-887
- 18F-FDG is a superior indicator of cognitive performance compared to 18F-florbetapir in Alzheimer’s disease and mild cognitive impairment evaluation: a global quantitative analysis.J Alzheimers Dis. 2019; 70: 1197-1207
- PET/MRI for neurologic applications.J Nucl Med. 2012; 53: 1916-1925
- Alzheimer’s disease: past, present, and future.J Int Neuropsychol Soc. 2017; 23: 818-831
- Mild cognitive impairment.Clin Geriatr Med. 2017; 33: 325-337
- Suboptimal validity of amyloid imaging-based diagnosis and management of Alzheimer’s disease: why it is time to abandon the approach.Eur J Nucl Med Mol Imaging. 2020; 47: 225-230
- Integrated 18F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging (18F-FDG PET/MRI), a multimodality approach for comprehensive evaluation of dementia patients: a pictorial essay.Indian J Radiol Imaging. 2015; 25: 342-352
- Advances in clinical PET/MRI instrumentation.PET Clin. 2016; 11: 95-103
- Comparison of values of CT and MRI imaging in the diagnosis of hepatocellular carcinoma and analysis of prognostic factors.Oncol Lett. 2019; 17: 1184-1188
- 18)F-NaF and (18)F-FDG as molecular probes in the evaluation of atherosclerosis.Eur J Nucl Med Mol Imaging. 2018; 45: 2190-2200
- PET/MR imaging of atherosclerosis: initial experience and outlook.Am J Nucl Med Mol Imaging. 2013; 3: 393-396
- Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.Circulation. 2002; 105: 2708-2711
- The role of radionuclide imaging in epilepsy. Part 1: sporadic temporal and extratemporal lobe epilepsy.J Nucl Med Technol. 2017; 45: 14-21
- Validation of FDG-PET/MRI coregistration in nonlesional refractory childhood epilepsy.Epilepsia. 2011; 52: 2216-2224
- Subsequent experience in hybrid PET-MRI for evaluation of refractory focal onset epilepsy.Seizure. 2018; 61: 128-134
- Initial experience in hybrid PET-MRI for evaluation of refractory focal onset epilepsy.Seizure. 2015; 31: 1-4
- Concurrent functional and metabolic assessment of brain tumors using hybrid PET/MR imaging.J Neurooncol. 2016; 127: 287-293
- The neurometabolic cascade of concussion.J Athl Train. 2001; 36: 228-235
- Neuroimaging in patients with head injury.Semin Nucl Med. 2003; 33: 136-147
- FDG-PET imaging in mild traumatic brain injury: a critical review.Front Neuroenergetics. 2014; 5 (Available at:): 13
- Post-concussive symptoms in children with mild traumatic brain injury.Neuropsychology. 2010; 24: 148-159
- [18F]FDG-PET combined with MRI elucidates the pathophysiology of traumatic brain injury in rats.J Neurotrauma. 2016; 34: 1074-1085
- Magnetic resonance-based motion correction for positron emission tomography imaging.Semin Nucl Med. 2013; 43: 60-67
- MR-based cardiac and respiratory motion-compensation techniques for PET-MR imaging.PET Clin. 2016; 11: 179-191
- Motion-corrected whole-heart PET-MR for the simultaneous visualisation of coronary artery integrity and myocardial viability: an initial clinical validation.Eur J Nucl Med Mol Imaging. 2018; 45: 1975-1986
- Correction of respiratory and cardiac motion in cardiac PET/MR using MR-based motion modeling.Phys Med Biol. 2018; 63: 225011
- Performing magnetic resonance imaging in patients with implantable pacemakers and defibrillators: results of a European Heart Rhythm Association survey.Europace. 2012; 14: 1807-1809
- Myocardial perfusion quantification using simultaneously acquired (13) NH3-ammonia PET and dynamic contrast-enhanced MRI in patients at rest and stress.Magn Reson Med. 2018; 80: 2641-2654
- Feasibility of simultaneous PET-MR perfusion using a novel cardiac perfusion phantom.Eur J Hybrid Imaging. 2017; 1: 4
- Hybrid PET/MR imaging of the heart: feasibility and initial results.Radiology. 2013; 268: 366-373
- Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunction.Circ Cardiovasc Imaging. 2011; 4: 381-391
- The future of molecular imaging.JACC Cardiovasc Imaging. 2011; 4: 799-806
- Molecular imaging of the chemokine receptor CXCR4 after acute myocardial infarction.JACC Cardiovasc Imaging. 2015; 8: 1417-1426
- Clinical use of cardiac PET/MRI: current state-of-the-art and potential future applications.Jpn J Radiol. 2018; 36: 313-323
- Prospective evaluation of 18F-fluorodeoxyglucose uptake in postischemic myocardium by simultaneous positron emission tomography/magnetic resonance imaging as a prognostic marker of functional outcome.Circ Cardiovasc Imaging. 2016; 9: e004316
- Detection of acute inflammatory myocarditis in Epstein Barr virus infection using hybrid 18F-fluoro-deoxyglucose–positron emission tomography/magnetic resonance imaging.Circ Am Heart Assoc. 2014; 130: 925-926
- ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.J Am Coll Cardiol. 2010; 55: 2614-2662
- Coronary artery plaque imaging: comparison of black-blood MRI and 64-multidetector computed tomography.Chronic Dis Transl Med. 2016; 2: 159-165
- F-18 FDG uptake in the large arteries: a new observation.Clin Nucl Med. 2001; 26: 314-319
- FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries.Eur J Nucl Med Mol Imaging. 2008; 35: 562-569
- Delayed time-point 18F-FDG PET CT imaging enhances assessment of atherosclerotic plaque inflammation.Nucl Med Commun. 2013; 34: 860-867
- 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis.Circ Cardiovasc Imaging. 2014; 7: 371-378
- Common carotid artery molecular calcification assessed by 18F-NaF PET/CT is associated with increased cardiovascular disease risk: results from the CAMONA Study.J Nucl Med. 2017; 58: 34
- Coronary artery PET/MR imaging: feasibility, limitations, and solutions.JACC Cardiovasc Imaging. 2017; 10: 1103-1112
- Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies.Am Heart J. 1999; 138: 299-302
- Cardiac sarcoidosis.J Am Coll Cardiol. 2016; 68: 411-421
- Cardiac sarcoidosis: state of the art review.Cardiovasc Diagn Ther. 2016; 6: 50-63
- Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping.Am J Respir Crit Care Med. 2014; 189: 109-112
- Reduction in (1)(8)F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.J Nucl Cardiol. 2014; 21: 166-174
- Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.Eur Heart J Cardiovasc Imaging. 2018; 19: 757-767
- Diagnosis and treatment response evaluation of cardiac sarcoidosis using positron emission tomography/magnetic resonance imaging.Eur Heart J. 2014; 36: 550
- Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous (18)F-fluorocholine PET/MRI for primary prostate cancer characterization.Eur J Nucl Med Mol Imaging. 2015; 42: 1247-1256
- Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial).Eur J Nucl Med Mol Imaging. 2018; 45: 355-364
- Gallium 68 PSMA-11 PET/MR imaging in patients with intermediate- or high-risk prostate cancer.Radiology. 2018; 288: 495-505
- The rise of PSMA ligands for diagnosis and therapy of prostate cancer.J Nucl Med. 2016; 57: 79S-89S
- Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer.EJNMMI Res. 2017; 7: 77
- Prostate cancer evaluation using PET quantification in 68Ga-PSMA-11 PET/MR with attenuation correction of bones as a fifth compartment.Quant Imaging Med Surg. 2020; 10: 40-47
- Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and 18F-FDG PET/CT.Abdom Imaging. 2015; 40: 843-851
- Multiparametric FDG-PET/MRI of hepatocellular carcinoma: initial experience.Contrast Media Mol Imaging. 2018; 2018: 5638283
- Simultaneous time-of-flight PET/MR identifies the hepatic 90Y-resin distribution after radioembolization.Clin Nucl Med. 2020; 45: e92-e93
- Detection of liver metastases in patients with adenocarcinomas of the gastrointestinal tract: comparison of 18F-FDG PET/CT and MR imaging.Abdom Imaging. 2015; : 1213-1222https://doi.org/10.1007/s00261-014-0283-x
- Qualitative and quantitative image analysis of CT and MR imaging in patients with neuroendocrine liver metastases in comparison to 68 Ga-DOTATOC PET.Eur J Radiol. 2015; : 1593-1600https://doi.org/10.1016/j.ejrad.2015.04.009
- 18 F-FDG PET/MR imaging in patients with suspected liver lesions: value of liver-specific contrast agent gadobenate dimeglumine.PLoS One. 2017; 12: e0180349
- Colorectal cancer liver metastases: diagnostic performance and prognostic value of PET/MR imaging.Radiology. 2016; 280: 782-792
- Diagnostic performance of [18F]FDG-PET/MRI for liver metastasis in patients with primary malignancy: a systematic review and meta-analysis.Eur Radiol. 2019; : 3553-3563https://doi.org/10.1007/s00330-018-5909-x
- Protocol requirements and diagnostic value of PET/MR imaging for liver metastasis detection.Eur J Nucl Med Mol Imaging. 2014; 41: 649-658
- Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA–enhanced MRI.J Nucl Med. 2010; 51: 692-699
- PET/MR imaging in cancers of the gastrointestinal tract.PET Clin. 2016; 11: 403-423
- Applications of PET-MRI in musculoskeletal disease.J Magn Reson Imaging. 2018; : 27-47https://doi.org/10.1002/jmri.26183
- PET/MR imaging: technical aspects and potential clinical applications.Radiology. 2013; 267: 26-44
- The role of radiological and hybrid imaging for muscle metastases: a systematic review.Eur Radiol. 2019; https://doi.org/10.1007/s00330-019-06555-4
- Musculoskeletal applications of PET/MR.Semin Musculoskelet Radiol. 2014; : 203-216https://doi.org/10.1055/s-0034-1371021
- Nononcologic applications of PET/CT and PET/MRI in musculoskeletal, orthopedic, and rheumatologic imaging: general considerations, techniques, and radiopharmaceuticals.J Nucl Med Technol. 2018; : 33-38https://doi.org/10.2967/jnmt.117.198663
- Applications of PET-computed tomography-magnetic resonance in the management of benign musculoskeletal disorders.PET Clin. 2019; 14: 1-15
- PET/MRI of metabolic activity in osteoarthritis: a feasibility study.J Magn Reson Imaging. 2017; 45: 1736-1745
- 18F-Sodium fluoride PET/CT and PET/MR imaging of bone and joint disorders.PET Clin. 2018; 13: 477-490
- Use of simultaneous 18F-FDG PET/MRI for the detection of spondylodiskitis.J Nucl Med. 2016; 57: 1396-1401
- PET/MRI in infection and inflammation.Semin Nucl Med. 2018; : 225-241https://doi.org/10.1053/j.semnuclmed.2018.02.003
- PET/MR imaging in musculoskeletal disorders.PET Clin. 2016; 11: 453-463
- PET/MR imaging: a critical appraisal [Internet].J Nucl Med. 2014; : 56S-58Shttps://doi.org/10.2967/jnumed.113.129270
- Does PET/MR imaging improve cancer assessments? literature evidence from more than 900 patients.J Nucl Med. 2014; 55: 59S-62S
- 18F-FDG PET/CT and PET/MRI perform equally well in cancer: evidence from studies on more than 2,300 patients.J Nucl Med. 2016; 57: 420-430
- PET and MRI: is the whole greater than the sum of its parts?.Cancer Res. 2016; 76: 6163-6166
- Software-based PET-MR image coregistration: combined PET-MRI for the rest of us!.Pediatr Radiol. 2016; 46: 1552-1561
- Simultaneous whole-body time-of-flight 18F-FDG PET/MRI: a pilot study comparing SUVmax with PET/CT and assessment of MR image quality.Clin Nucl Med. 2015; 40: 1-8
- Simultaneous MR/PET imaging of the human brain: feasibility study.Radiology. 2008; 248: 1028-1035
- A first: simultaneous PET/MR images of the brain debut, increase molecular imaging capabilities.ScienceDaily. 2007; (Available at:)
- Variations in PET/MRI operations: results from an international survey among 39 active sites.J Nucl Med. 2016; 57: 2016-2021
- History and future technical innovation in positron emission tomography.J Med Imaging (Bellingham). 2017; 4: 011013
- A combined PET/CT scanner for clinical oncology.J Nucl Med. 2000; 41: 1369-1379
- A combined PET/CT scanner: the choices.J Nucl Med. 2001; : 533-534
- PET/CT: essentials for clinical practice.Springer Science & Business Media, New York2006
- PET imaging market summary report 2019. IMV Medical Information Division, Arlington2019
- NMR-PET scanner apparatus [Internet]. US Patent.(Available at:) (Accessed February 18, 2020)
- Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging?.Semin Nucl Med. 2008; 38: 199-208
- Investigating the state-of-the-art in whole-body MR-based attenuation correction: an intra-individual, inter-system, inventory study on three clinical PET/MR systems.MAGMA. 2016; 29: 75-87
- Current image acquisition options in PET/MR.Semin Nucl Med. 2015; 45: 192-200
- Combined PET/MRI: from status quo to status go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15–19, 2016; Tübingen, Germany [Internet].Mol Imaging Biol. 2016; : 637-650https://doi.org/10.1007/s11307-016-0993-2
- Current status of hybrid PET/MRI in oncologic imaging.AJR Am J Roentgenol. 2016; 206: 162-172
- PET/MRI: a luxury or a necessity?.Rev Esp Med Nucl Imagen Mol. 2016; : 313-320https://doi.org/10.1016/j.remnie.2016.07.002
- Clinical PET/MRI: 2018 Update.Am J Roentgenol. 2018; : 295-313https://doi.org/10.2214/ajr.18.20001
- Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice.J Nucl Med. 2014; 55: 88-94
- An overview of PET/MR, focused on clinical applications.Abdom Radiol (NY). 2017; 42: 631-644
- FDG whole-body PET/MRI in oncology: a systematic review.Nucl Med Mol Imaging. 2017; 51: 22-31
- EANM–ESR white paper on multimodality imaging. A white paper for a black project: towards the decline of nuclear medicine as an independent specialty in Europe? [Internet].Eur J Nucl Med Mol Imaging. 2008; : 674-676https://doi.org/10.1007/s00259-008-0723-3
- A decade of combined imaging: from a PET attached to a CT to a PET inside an MR.Eur J Nucl Med Mol Imaging. 2009; 36 (Springer): 1-2
- A look ahead: PET/MR versus PET/CT.Eur J Nucl Med Mol Imaging. 2009; 36: S3-S9
- From PET/CT to PET/MRI: advances in instrumentation and clinical applications.Mol Pharm. 2014; 11: 3798-3809
- Integrated whole body MR/PET: where are we?.Korean J Radiol. 2015; 16: 32-49
- Combined PET/MR: the real work has just started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17–21, 2014, Tübingen, Germany.Mol Imaging Biol. 2015; : 297-312https://doi.org/10.1007/s11307-014-0818-0
- Practical PET respiratory motion correction in clinical PET/MR.J Nucl Med. 2015; : 890-896https://doi.org/10.2967/jnumed.114.151779
- Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo).Eur J Nucl Med Mol Imaging. 2018; 45: 2147-2154
- Cardiac and respiratory motion correction for simultaneous cardiac PET/MR.J Nucl Med. 2017; 58: 846-852
- MR-based respiratory and cardiac motion correction for PET imaging.Med Image Anal. 2017; 42: 129-144
- Fetal radiation dose from 18F-FDG in pregnant patients imaged with PET, PET/CT, and PET/MR [Internet].J Nucl Med. 2015; : 1218-1222https://doi.org/10.2967/jnumed.115.157032
Article info
Publication history
Published online: July 14, 2020
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
